FogPharma announced a $145 million Series E financing round led by Nextech Invest to support ongoing clinical development of FOG-001 and accelerate Helicon peptide portfolio.
FogPharma announced a $145 million Series E financing round led by Nextech Invest to support ongoing clinical development of FOG-001 and accelerate Helicon peptide portfolio.
03/01/24, 12:11 PM
Location
cambridgeMoney raised
$145 million
Industry
biotechnology
health care
therapeutics
pharmaceutical
Round Type
series e
Investors
Milky Way Investments, Invus, Ven Bio Partners, Farallon Capital Management, T. Rowe Price Associates, Inc., Cormorant Asset Management, Gv, Fidelity Management & Research Company, Arch Venture Partners, Sixty Degree Capital, Catalio Capital Management, Symbiosis, Foresite Capital, Samsara Biocapital, Marshall Wace, General Catalyst, Rock Springs Capital, Ra Capital Management, Nextech Invest
FogPharma successfully closed a $145 million Series E financing round led by Nextech Invest, with participation from other new investors including RA Capital Management, Rock Springs Capital, General Catalyst, Marshall Wace, Samsara Biocapital, Foresite Capital, Symbiosis, Catalio Capital Management, Sixty Degree Capital, and former chairman and CEO of Johnson & Johnson, Alex Gorsky. The financing will support the ongoing clinical development of FOG-001 and accelerate the development of its robust portfolio of unique discovery programs.
Company Info
Location
30 acorn park drive
cambridge, massachusetts, united states
Additional Info
FogPharma is developing a new class of drugs to address the limitations of today’s precision medicines and achieve universal druggability. The company is pioneering the discovery, development and commercialization of HeliconTM peptides, a new drug modality that uniquely combines the broad targeting power of monoclonal antibodies with the cell-penetrating ability of small molecules. HeliconTM peptides hold the promise, not only to drug nearly all human disease drivers, but also to do so with unrivaled speed and scalability.